Respiratory Drug Delivery 2021 (RDD 2021) replaces RDD Europe 2021, and will be available online with enhanced features. RDD 2021 will still be the must attend, premier international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery that you expect - only now available to a worldwide audience in a unique virtual conference experience.

While the global pandemic is keeping us physically apart, RDD 2021 is evolving to bring us closer in a new virtual format. Gone are separate rooms for podium, workshop, exhibition and poster sessions. Welcome to on-screen Knowledge Spaces, where quality curated science and services are arranged by theme.

Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient.

Check out this virtual event at RDD 2021